Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
18.20
-0.30 (-1.62%)
At close: Nov 20, 2024, 4:00 PM
18.19
-0.01 (-0.05%)
After-hours: Nov 20, 2024, 7:27 PM EST
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $67.55 million as of November 21, 2024. Its market cap has increased by 18.62% in one year.
Market Cap
67.55M
Enterprise Value
1.76M
1-Year Change
18.62%
Ranking
Category
Stock Price
$18.20
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $67.55M, a decrease of -87.79%. That is a compound annual growth rate of -40.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 68.66M | 38.01% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 68.34M |
| CytomX Therapeutics | 68.06M |
| BeyondSpring | 67.90M |
| AlloVir | 67.89M |
| Cue Biopharma | 66.23M |
| Cryo-Cell International | 65.71M |
| InterCure | 65.08M |
| Aileron Therapeutics | 65.00M |